Wedge Industrial Co.,Ltd. (SHE:000534)

Market Cap	12.02B +51.3%
Revenue (ttm)	1.33B +10.8%
Net Income	202.99M -5.2%
EPS	0.40 -5.5%
Shares Out	482.35M
PE Ratio	62.53
Forward PE	44.50
Dividend	0.05 (0.20%)
Ex-Dividend Date	Aug 14, 2025

Volume	23,802,076
Open	23.64
Previous Close	24.19
Day's Range	23.64 - 25.67
52-Week Range	14.90 - 49.14
Beta	0.48
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About Wedge Industrial

Wedge Industrial Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of micro-ecological live bacteria products, superalloys, and related products in China. It offers microecological preparations, such as bifidobacterium lactobacillus triple live bacteria tablets under the Golden Bifidobacterium brand; vaginal lactobacillus live capsules under the Dingjun Sheng brand; dual-span microecological live bacteria drugs under the Jin Shuangqi brand; and vaginal microecological live bacteria drug for ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 1,438
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000534

Financial Performance

In 2025, Wedge Industrial's revenue was 1.29 billion, an increase of 19.62% compared to the previous year's 1.08 billion. Earnings were 197.02 million, an increase of 2.22%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 4, 2026

Data Sources Report a data error